Clinical Trial Update: National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF) [Phase 1]

View source ↗

Summary

Phase I study evaluating mesenchymal stem-cell therapy for acute-on-chronic liver failure; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Acute-On-Chronic Liver Failure | Phase 1 | Status: NOT_YET_RECRUITING